4th Quarter - Report

THE D MAJOR GROUP for EMD SERONO, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Monitor accelerated approval and other FDA-related provisions as included in HR 2167, the "Consolidated Appropriations Act for FY2023."

LobbyistCovered position, as disclosed
DIANE MAJOR Health Policy Analyst for Senate Repub. Policy Com't.
BRENDA REESE Conference Coordinator for House Republican Conf.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2167 (117th)

Defense DEF

Monitor DOD Tricare coverage of fertility treatments for active duty personnel.

LobbyistCovered position, as disclosed
DIANE MAJOR Health Policy Analyst for Senate Repub.Policy Com't.
BRENDA REESE Conference Coordinator for House Repub. Conference

Contacted: SENATE

Copyright/Patent/Trademark CPT

Monitor issues concerning "march-in" rights as related to pharmaceutical research and development.

LobbyistCovered position, as disclosed
DIANE MAJOR Health Policy Analyst for Senate Republican Policy Committee
BRENDA REESE Conference Coordinator for House Republican Conference

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Monitor the impact of HR 5376, the "Inflation Reduction Act," on pharmaceutical research and development -- specifically, provisions affecting women's health, oncology and immunotherapy discoveries.

LobbyistCovered position, as disclosed
DIANE MAJOR Health Policy Analyst for Senate Republican Policy Committee
BRENDA REESE Conference Coordinator for House Republican Conference

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.